BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Puig-saus C, Rojas LA, Laborda E, Figueras A, Alba R, Fillat C, Alemany R. iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy. Gene Ther 2014;21:767-74. [DOI: 10.1038/gt.2014.52] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Mahmoud K, Swidan S, El-nabarawi M, Teaima M. Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01309-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Hennigs JK, Matuszcak C, Trepel M, Körbelin J. Vascular Endothelial Cells: Heterogeneity and Targeting Approaches. Cells 2021;10:2712. [PMID: 34685692 DOI: 10.3390/cells10102712] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
3 Wang H, Zhou J, Fu Y, Zheng Y, Shen W, Zhou J, Yin T. Deeply Infiltrating iRGD-Graphene Oxide for the Intensive Treatment of Metastatic Tumors through PTT-Mediated Chemosensitization and Strengthened Integrin Targeting-Based Antimigration. Adv Healthc Mater 2021;10:e2100536. [PMID: 34137204 DOI: 10.1002/adhm.202100536] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
4 Núñez-Manchón E, Farrera-Sal M, Otero-Mateo M, Castellano G, Moreno R, Medel D, Alemany R, Villanueva E, Fillat C. Transgene codon usage drives viral fitness and therapeutic efficacy in oncolytic adenoviruses. NAR Cancer 2021;3:zcab015. [PMID: 34316705 DOI: 10.1093/narcan/zcab015] [Reference Citation Analysis]
5 Raimondi G, Gea-Sorlí S, Otero-Mateo M, Fillat C. Inhibition of miR-222 by Oncolytic Adenovirus-Encoded miRNA Sponges Promotes Viral Oncolysis and Elicits Antitumor Effects in Pancreatic Cancer Models. Cancers (Basel) 2021;13:3233. [PMID: 34203557 DOI: 10.3390/cancers13133233] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Farrera-Sal M, Moreno R, Mato-Berciano A, Maliandi MV, Bazan-Peregrino M, Alemany R. Hyaluronidase expression within tumors increases virotherapy efficacy and T cell accumulation. Mol Ther Oncolytics 2021;22:27-35. [PMID: 34377767 DOI: 10.1016/j.omto.2021.05.009] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Fang X, Lui KH, Li S, Lo WS, Li X, Gu Y, Wong WT. Multifunctional Nanotheranostic Gold Nanocage/Selenium Core-Shell for PAI-Guided Chemo-Photothermal Synergistic Therapy in vivo. Int J Nanomedicine 2020;15:10271-84. [PMID: 33364758 DOI: 10.2147/IJN.S275846] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
8 Wang H, Najibi AJ, Sobral MC, Seo BR, Lee JY, Wu D, Li AW, Verbeke CS, Mooney DJ. Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors. Nat Commun 2020;11:5696. [PMID: 33173046 DOI: 10.1038/s41467-020-19540-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
9 Farrera-Sal M, de Sostoa J, Nuñez-Manchón E, Moreno R, Fillat C, Bazan-Peregrino M, Alemany R. Arming Oncolytic Adenoviruses: Effect of Insertion Site and Splice Acceptor on Transgene Expression and Viral Fitness. Int J Mol Sci 2020;21:E5158. [PMID: 32708234 DOI: 10.3390/ijms21145158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yan J, Zhu R, Wu F, Zhao Z, Ye H, Hou M, Liu Y, Yin L. iRGD-reinforced, photo-transformable nanoclusters toward cooperative enhancement of intratumoral penetration and antitumor efficacy. Nano Res 2020;13:2706-15. [DOI: 10.1007/s12274-020-2913-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
11 Scodeller P, Asciutto EK. Targeting Tumors Using Peptides. Molecules 2020;25:E808. [PMID: 32069856 DOI: 10.3390/molecules25040808] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
12 Barry MA, Rubin JD, Lu SC. Retargeting adenoviruses for therapeutic applications and vaccines. FEBS Lett 2020;594:1918-46. [PMID: 31944286 DOI: 10.1002/1873-3468.13731] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
13 Zhang D, Chu Y, Qian H, Qian L, Shao J, Xu Q, Yu L, Li R, Zhang Q, Wu F, Liu B, Liu Q. Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer. Int J Nanomedicine 2020;15:735-47. [PMID: 32099362 DOI: 10.2147/IJN.S231448] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
14 Zhang Y, Li M, Gao X, Chen Y, Liu T. Nanotechnology in cancer diagnosis: progress, challenges and opportunities. J Hematol Oncol 2019;12:137. [PMID: 31847897 DOI: 10.1186/s13045-019-0833-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 88] [Article Influence: 14.0] [Reference Citation Analysis]
15 Ding J, Chen J, Gao L, Jiang Z, Zhang Y, Li M, Xiao Q, Lee SS, Chen X. Engineered nanomedicines with enhanced tumor penetration. Nano Today 2019;29:100800. [DOI: 10.1016/j.nantod.2019.100800] [Cited by in Crossref: 129] [Cited by in F6Publishing: 161] [Article Influence: 43.0] [Reference Citation Analysis]
16 Emdad L, Bhoopathi P, Talukdar S, Pradhan AK, Sarkar D, Wang XY, Das SK, Fisher PB. Recent insights into apoptosis and toxic autophagy: The roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic. Semin Cancer Biol 2020;66:140-54. [PMID: 31356866 DOI: 10.1016/j.semcancer.2019.07.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
17 Zuo H. iRGD: A Promising Peptide for Cancer Imaging and a Potential Therapeutic Agent for Various Cancers. J Oncol 2019;2019:9367845. [PMID: 31346334 DOI: 10.1155/2019/9367845] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
18 Erel-Akbaba G, Carvalho LA, Tian T, Zinter M, Akbaba H, Obeid PJ, Chiocca EA, Weissleder R, Kantarci AG, Tannous BA. Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy. ACS Nano 2019;13:4028-40. [PMID: 30916923 DOI: 10.1021/acsnano.8b08177] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 27.3] [Reference Citation Analysis]
19 Sheng Y, Wang Z, Ngandeu Neubi GM, Cheng H, Zhang C, Zhang H, Wang R, Zhou J, Ding Y. Lipoprotein-inspired penetrating nanoparticles for deep tumor-targeted shuttling of indocyanine green and enhanced photo-theranostics. Biomater Sci 2019;7:3425-37. [DOI: 10.1039/c9bm00588a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
20 Rovira-Rigau M, Raimondi G, Marín MÁ, Gironella M, Alemany R, Fillat C. Bioselection Reveals miR-99b and miR-485 as Enhancers of Adenoviral Oncolysis in Pancreatic Cancer. Mol Ther 2019;27:230-43. [PMID: 30341009 DOI: 10.1016/j.ymthe.2018.09.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
21 Alipour M, Majidi A, Molaabasi F, Sheikhnejad R, Hosseinkhani S. In vivo tumor gene delivery using novel peptideticles: pH‐responsive and ligand targeted core–shell nanoassembly. Int J Cancer 2018;143:2017-28. [DOI: 10.1002/ijc.31577] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
22 Wonder E, Simón-Gracia L, Scodeller P, Majzoub RN, Kotamraju VR, Ewert KK, Teesalu T, Safinya CR. Competition of charge-mediated and specific binding by peptide-tagged cationic liposome-DNA nanoparticles in vitro and in vivo. Biomaterials 2018;166:52-63. [PMID: 29544111 DOI: 10.1016/j.biomaterials.2018.02.052] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
23 Seidi K, Neubauer HA, Moriggl R, Jahanban-Esfahlan R, Javaheri T. Tumor target amplification: Implications for nano drug delivery systems. J Control Release 2018;275:142-61. [PMID: 29454742 DOI: 10.1016/j.jconrel.2018.02.020] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 13.3] [Reference Citation Analysis]
24 Al-Zaher AA, Moreno R, Fajardo CA, Arias-Badia M, Farrera M, de Sostoa J, Rojas LA, Alemany R. Evidence of Anti-tumoral Efficacy in an Immune Competent Setting with an iRGD-Modified Hyaluronidase-Armed Oncolytic Adenovirus. Mol Ther Oncolytics 2018;8:62-70. [PMID: 29888319 DOI: 10.1016/j.omto.2018.01.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
25 Ai S, Zhen S, Liu Z, Sun F, He X, Chu F, Guan W, Wang J. An iRGD peptide conjugated heparin nanocarrier for gastric cancer therapy. RSC Adv 2018;8:30012-20. [DOI: 10.1039/c8ra05071f] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
26 Ghosh D, Peng X, Leal J, Mohanty R. Peptides as drug delivery vehicles across biological barriers. J Pharm Investig 2018;48:89-111. [PMID: 29963321 DOI: 10.1007/s40005-017-0374-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
27 Le Joncour V, Laakkonen P. Seek & Destroy, use of targeting peptides for cancer detection and drug delivery. Bioorg Med Chem 2018;26:2797-806. [PMID: 28893601 DOI: 10.1016/j.bmc.2017.08.052] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 8.0] [Reference Citation Analysis]
28 Moreno R, Rojas LA, Villellas FV, Soriano VC, García-Castro J, Fajardo CA, Alemany R. Human Menstrual Blood-Derived Mesenchymal Stem Cells as Potential Cell Carriers for Oncolytic Adenovirus. Stem Cells Int 2017;2017:3615729. [PMID: 28781596 DOI: 10.1155/2017/3615729] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
29 Zhou Z, Liu X, Zhu D, Wang Y, Zhang Z, Zhou X, Qiu N, Chen X, Shen Y. Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration. Adv Drug Deliv Rev 2017;115:115-54. [PMID: 28778715 DOI: 10.1016/j.addr.2017.07.021] [Cited by in Crossref: 231] [Cited by in F6Publishing: 229] [Article Influence: 46.2] [Reference Citation Analysis]
30 Ruoslahti E. Tumor penetrating peptides for improved drug delivery. Adv Drug Deliv Rev 2017;110-111:3-12. [PMID: 27040947 DOI: 10.1016/j.addr.2016.03.008] [Cited by in Crossref: 229] [Cited by in F6Publishing: 226] [Article Influence: 45.8] [Reference Citation Analysis]
31 Song X, Wan Z, Chen T, Fu Y, Jiang K, Yi X, Ke H, Dong J, Yang L, Li L, Sun X, Gong T, Zhang Z. Development of a multi-target peptide for potentiating chemotherapy by modulating tumor microenvironment. Biomaterials 2016;108:44-56. [PMID: 27619239 DOI: 10.1016/j.biomaterials.2016.09.001] [Cited by in Crossref: 61] [Cited by in F6Publishing: 68] [Article Influence: 10.2] [Reference Citation Analysis]
32 Rojas LA, Condezo GN, Moreno R, Fajardo CA, Arias-badia M, San Martín C, Alemany R. Albumin-binding adenoviruses circumvent pre-existing neutralizing antibodies upon systemic delivery. Journal of Controlled Release 2016;237:78-88. [DOI: 10.1016/j.jconrel.2016.07.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
33 Dong P, Cai H, Chen L, Li Y, Yuan C, Wu X, Shen G, Zhou H, Zhang W, Li L. Biodistribution and evaluation of 131 I-labeled neuropilin-binding peptide for targeted tumor imaging. Contrast Media Mol Imaging 2016;11:467-74. [PMID: 27527756 DOI: 10.1002/cmmi.1708] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
34 Herranz-Blanco B, Shahbazi MA, Correia AR, Balasubramanian V, Kohout T, Hirvonen J, Santos HA. pH-Switch Nanoprecipitation of Polymeric Nanoparticles for Multimodal Cancer Targeting and Intracellular Triggered Delivery of Doxorubicin. Adv Healthc Mater 2016;5:1904-16. [PMID: 27245691 DOI: 10.1002/adhm.201600160] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
35 Simón-Gracia L, Hunt H, Scodeller P, Gaitzsch J, Kotamraju VR, Sugahara KN, Tammik O, Ruoslahti E, Battaglia G, Teesalu T. iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes. Biomaterials 2016;104:247-57. [PMID: 27472162 DOI: 10.1016/j.biomaterials.2016.07.023] [Cited by in Crossref: 79] [Cited by in F6Publishing: 93] [Article Influence: 13.2] [Reference Citation Analysis]
36 Przysiecka Ł, Michalska M, Nowaczyk G, Peplińska B, Jesionowski T, Schneider R, Jurga S. iRGD peptide as effective transporter of CuInZnxS2+x quantum dots into human cancer cells. Colloids Surf B Biointerfaces 2016;146:9-18. [PMID: 27244046 DOI: 10.1016/j.colsurfb.2016.05.041] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
37 Zhang J, Hu J, Chan HF, Skibba M, Liang G, Chen M. iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy. Nanomedicine 2016;12:1303-11. [PMID: 26964482 DOI: 10.1016/j.nano.2016.01.017] [Cited by in Crossref: 53] [Cited by in F6Publishing: 60] [Article Influence: 8.8] [Reference Citation Analysis]
38 Zhou G, Xu Y, Chen M, Cheng D, Shuai X. Tumor-penetrating peptide modified and pH-sensitive polyplexes for tumor targeted siRNA delivery. Polym Chem 2016;7:3857-63. [DOI: 10.1039/c6py00427j] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
39 Turner MA, Middha S, Hofherr SE, Barry MA. Comparison of the Life Cycles of Genetically Distant Species C and Species D Human Adenoviruses Ad6 and Ad26 in Human Cells. J Virol 2015;89:12401-17. [PMID: 26423951 DOI: 10.1128/JVI.01534-15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
40 Sun L, Wu Q, Peng F, Liu L, Gong C. Strategies of polymeric nanoparticles for enhanced internalization in cancer therapy. Colloids Surf B Biointerfaces 2015;135:56-72. [PMID: 26241917 DOI: 10.1016/j.colsurfb.2015.07.013] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 8.7] [Reference Citation Analysis]
41 Sugahara KN, Scodeller P, Braun GB, de Mendoza TH, Yamazaki CM, Kluger MD, Kitayama J, Alvarez E, Howell SB, Teesalu T, Ruoslahti E, Lowy AM. A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis. J Control Release 2015;212:59-69. [PMID: 26071630 DOI: 10.1016/j.jconrel.2015.06.009] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 7.1] [Reference Citation Analysis]
42 Durzyńska J, Przysiecka Ł, Nawrot R, Barylski J, Nowicki G, Warowicka A, Musidlak O, Goździcka-józefiak A. Viral and Other Cell-Penetrating Peptides as Vectors of Therapeutic Agents in Medicine. J Pharmacol Exp Ther 2015;354:32-42. [DOI: 10.1124/jpet.115.223305] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.7] [Reference Citation Analysis]
43 Zhang B, Gao Z, Sun M, Li H, Fan H, Chen D, Zheng J. Prognostic significance of VEGF-C, semaphorin 3F, and neuropilin-2 expression in oral squamous cell carcinomas and their relationship with lymphangiogenesis: VEGFC, sema3F, Nrp2 in OSCC. J Surg Oncol 2015;111:382-8. [DOI: 10.1002/jso.23842] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]